Institutional members access full text with Ovid®

Share this article on:

Uptake of breast cancer screening in women aged over 75years: a controversy to come?

Eisinger, Françoisa,b,c; Viguier, Jérômed; Blay, Jean-Yvesd; Morère, Jean-Françoise; Coscas, Yvanf; Roussel, Claireg; Pivot, Xavierh

European Journal of Cancer Prevention: January 2011 - Volume 20 - Issue - p S13–S15
doi: 10.1097/01.cej.0000391564.03265.3f
Supplement Articles

In France, the age range for organized screening for breast cancer is 50–74 years. From a layperson's perspective, thepublic health message focusing on a specific target population may be difficult to understand. The aim of this study is to assess how women aged over 75 years deal with this absence of screening recommendations for their age group. The population-based survey, EDIFICE, was carried out by telephone in 2008. Women were interviewed with regard to their behaviour, and in particular relating tobreast cancer screening. For 136 breast cancer-free women, aged 75 and above and who had undergone at least one mammography in their lifetime, the test had been done within the last 2 years for only 62 (51%) of them. Inamultiregression analysis, only one item (i.e. already having undergone at least five mammographies) was statistically associated with a higher rate of attendance (odds ratio=3.3, 95% confidence interval=1.03–11.1). According to our data, for women aged 75 and above, anestimated 17 000 000 Euros are spent each year on breast cancer screening in France, the net benefit of which is still unknown.

aDepartment of Anticipation and Follow-up of Cancer, Paoli-Calmettes Institute


cFaculty of Medicine, University of Aix-Marseille, Marseille

dDepartment of Cancer Screening, University Hospital Centre of Tours

eAvicenne University Hospital, Bobigny

fPorte de St Cloud Clinic, Boulogne-Billancourt

gRoche S.A., Neuilly-sur-Seine

hUniversity Hospital Jean Minjoz, Besançon, France

Correspondence to François Eisinger, Institut Paoli-Calmettes, 232Boulevard Sainte Marguerite, 13009 Marseille, France Tel: +33 4 91 22 35 41; fax: +33 4 91 22 38 57; e-mail:

© 2011 Lippincott Williams & Wilkins, Inc.